StockWatch: Recursion Slides on Data Update as New CEO Named
Investors in Recursion (NASDAQ: RXRX) seemed only mildly fazed by Wednesday’s series of company announcements. The artificial intelligence (AI)-based drug developer’s stock barely moved on Wednesday, then dropped on Thursday, after reporting mixed third- …